knowledge -WSS

knowledge

author：comprehensive 2025-08-12 06:44:53 - browse：5326

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Supreme Court strikes down use of affirmative action

hotspot

WSS

Jerome Adams on the need for new antivirals for Covid

Sophia Smith scores twice for US in in 3

Transgender women dream of pregnancy via uterus transplants

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Burning questions about Delta and the next phase of the Covid pandemic

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

hotspot

knowledge

hotspot

Heart attack and stroke risk calculators need revising

Peter Hotez and the public health issue of online harassment

The high cost of giving birth even with insurance

Bright Health sells Medicare Advantage business to Molina

How one medical school became remarkably diverse

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Wildfire smoke exposes gaps in outdoor worker protections

Novartis develops a rapidly manufactured CAR

After affirmative action ruling, medical educators look to 'holistic review'

Medical records are filled with copy

explore

Anesthesiologist group: stop taking Ozempic before surgery

In Memoriam: Notable people who died in 2023

Affirmative action in medical school literally saved lives

The response to Covid

Hollywood unions extend contract negotiations for actors

How to protect coverage of PrEP

hotspot

hotspot

leisure time

entertainment